ES2045075T3 - Procedimiento para la preparacion de proteinas de plasmodium falciparum. - Google Patents

Procedimiento para la preparacion de proteinas de plasmodium falciparum.

Info

Publication number
ES2045075T3
ES2045075T3 ES88121299T ES88121299T ES2045075T3 ES 2045075 T3 ES2045075 T3 ES 2045075T3 ES 88121299 T ES88121299 T ES 88121299T ES 88121299 T ES88121299 T ES 88121299T ES 2045075 T3 ES2045075 T3 ES 2045075T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
plasmodium falciparum
dna sequences
falciparum proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88121299T
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Dr Knapp
Erika Dr Hundt
Burkhard Dr Enders
Hans Dr Kupper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2045075T3 publication Critical patent/ES2045075T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES88121299T 1987-12-30 1988-12-20 Procedimiento para la preparacion de proteinas de plasmodium falciparum. Expired - Lifetime ES2045075T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3744495 1987-12-30
DE3831351A DE3831351A1 (de) 1987-12-30 1988-09-15 Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung

Publications (1)

Publication Number Publication Date
ES2045075T3 true ES2045075T3 (es) 1994-01-16

Family

ID=25863316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88121299T Expired - Lifetime ES2045075T3 (es) 1987-12-30 1988-12-20 Procedimiento para la preparacion de proteinas de plasmodium falciparum.

Country Status (11)

Country Link
EP (1) EP0322712B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JPH022356A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU625315B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3831351A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK727688A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2045075T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI99144C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3007126T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL88818A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT89363B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU48126B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4041836A1 (de) * 1990-12-24 1992-06-25 Behringwerke Ag Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten, ihre herstellung und verwendung
AU4996193A (en) * 1992-08-07 1994-03-03 Schering Corporation Pfemp3 malaria antigen, analogs, antibodies and uses thereof
EP0969714A4 (en) * 1997-01-10 2004-10-06 Univ California RG NUCLEIC ACIDS FOR THE IMPLEMENTATION OF DISEASE RESISTANCE IN PLANTS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340103C (en) * 1984-02-22 1998-10-27 Karel Gerrit Odink Cloning of dna for protozoal antigens
EP0309746A1 (de) * 1987-09-08 1989-04-05 F. Hoffmann-La Roche Ag Antimalaria-Vakzine

Also Published As

Publication number Publication date
AU625315B2 (en) 1992-07-09
FI886001L (fi) 1989-07-01
DK727688A (da) 1989-07-01
GR3007126T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-07-30
JPH11318475A (ja) 1999-11-24
AU2761988A (en) 1989-07-06
PT89363B (pt) 1993-08-31
DK727688D0 (da) 1988-12-29
EP0322712B1 (de) 1992-11-25
FI99144B (fi) 1997-06-30
EP0322712A3 (en) 1990-05-02
DE3831351A1 (de) 1989-07-13
EP0322712A2 (de) 1989-07-05
FI99144C (fi) 1997-10-10
PT89363A (pt) 1989-12-29
YU48126B (sh) 1997-05-28
DE3876227D1 (de) 1993-01-07
JPH022356A (ja) 1990-01-08
IL88818A (en) 1997-02-18
YU237588A (en) 1991-06-30
IL88818A0 (en) 1989-07-31

Similar Documents

Publication Publication Date Title
ES2164794T3 (es) Dna que codifica cd 19.
IT8719973A0 (it) Espressione e purificazione di una gene proteina htlv-iii gag/env.
FI882456L (fi) Human proapolipoprotein a-i expression.
DK511381A (da) Mucopolysaccaharider som har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
ES2058566T3 (es) Sondas de hibridacion para detectar las cepas de neisseria.
AU592749B2 (en) Cloning of dna for protozoal antigens
DE59912185D1 (de) Verwendung von hsp70 protein
CY1105331T1 (el) Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
ES2104596T3 (es) Nuevos polipeptidos, secuencias de adn que permiten su expresion, metodo de preparacion, y utilizacion.
ES2042488T3 (es) Productos intermedios para la produccion de podofilotoxina, y compuestos relacionados y procedimientos para su preparacion y utilizacion.
ES2058486T3 (es) Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis.
ES2045075T3 (es) Procedimiento para la preparacion de proteinas de plasmodium falciparum.
DK656588D0 (da) Substituerede hydroxylaminer, deres fremstilling og anvendelse som laegemidler, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
ES2156902T3 (es) Peptidos que inducen la produccion de anticuerpos neutralizantes contra cepas de vih-1 geneticamente divergentes.
DE3782560D1 (de) Hefestaemme zur expression fremder gene.
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
IT8222411A0 (it) Procedimento per la produzione di interferone da geni umani.
AU1092588A (en) Expression of the p. falciparum circumsporozoite protein by yeast
DE69929683D1 (de) Antisense modulierung von lfa-3
MY104975A (en) Protease, reverse transcriptase and endonuclease of retrovirus, and method for producing these enzymes.
ES2061655T3 (es) Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos.
ATE370746T1 (de) Ihnv g fusionsprotein für die immunstimulation
FI901764A0 (fi) Syntetisk dna-sekvens, som kodar human insulinlik vaextfaktor ii.
MX14385A (es) Proteinas con secuencias de adn especificas para malaria, sus productos de expresion y su empleo y procedimiento para la preparacion de las mismas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322712

Country of ref document: ES